GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Patterson Companies Inc (NAS:PDCO) » Definitions » Intrinsic Value: Projected FCF

Patterson (Patterson) Intrinsic Value: Projected FCF

: $-50.68 (As of Today)
View and export this data going back to 1992. Start your Free Trial

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-04-23), Patterson's Intrinsic Value: Projected FCF is $-50.68. The stock price of Patterson is $25.93. Therefore, Patterson's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for Patterson's Intrinsic Value: Projected FCF or its related term are showing as below:

During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Patterson was 73.67. The lowest was 0.66. And the median was 1.17.

PDCO's Price-to-Projected-FCF is not ranked *
in the Medical Distribution industry.
Industry Median: 1.015
* Ranked among companies with meaningful Price-to-Projected-FCF only.

Patterson Intrinsic Value: Projected FCF Historical Data

The historical data trend for Patterson's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Patterson Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Intrinsic Value: Projected FCF
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.32 12.15 -2.08 -16.29 -31.28

Patterson Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Intrinsic Value: Projected FCF Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -30.00 -31.28 -38.71 -42.73 -50.68

Competitive Comparison

For the Medical Distribution subindustry, Patterson's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Patterson Price-to-Projected-FCF Distribution

For the Medical Distribution industry and Healthcare sector, Patterson's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Patterson's Price-to-Projected-FCF falls into.



Patterson Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get Patterson's Free Cash Flow(6 year avg) = $-574.19.

Patterson's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Jan24)*0.8)/Shares Outstanding (Diluted Average)
=(9.5203515959648*-574.192+971.482*0.8)/92.519
=-50.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Patterson  (NAS:PDCO) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Patterson's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=25.93/-50.684984960821
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Patterson Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Patterson's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Patterson (Patterson) Business Description

Traded in Other Exchanges
Address
1031 Mendota Heights Road, Saint Paul, MN, USA, 55120
Patterson Companies Inc is a leading dental distributor and wholesaler of consumable products and equipment operating through two business segments, Patterson Dental, and Patterson Animal Health. The company's segment includes Dental, Animal Health, and Corporate. It generates maximum revenue from the Animal Health segment. Geographically, it derives a majority of its revenue from the United States.
Executives
Kevin Michael Barry officer: Chief Financial Officer 1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55120
Donald Zurbay officer: Chief Financial Officer C/O ST. JUDE MEDICAL, INC., ONE ST JUDE MEDICAL DRIVE, ST. PAUL MN 55117
Timothy E Rogan officer: President - Dental 1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55120
Les B Korsh officer: VP, General Counsel 1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55110
Meenu Agarwal director 7246 E MERCER WAY, MERCER ISLAND WA 98040
Samantha L Bergeson officer: CHRO 1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55120
Andrea L. Frohning officer: Chief Human Resources Officer C/O DENTSLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Philip Mckoy director 120 BROADWAY, SUITE 200, SANTA MONICA CA 90401
Jody H Feragen director 1 HORMEL PLACE, AUSTIN TX 55912
Eric R Shirley officer: President-Patterson Dental 1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55120
Francis Joseph Malecha director 9900 WEST 109TH STREET, SUITE 100, OVERLAND PARK KS 66210
Robert Frenzel director 414 NICOLLET MALL, MINNEAPOLIS MN 55401
Dennis W Goedken officer: Interim CFO 1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55120
Ann B Gugino officer: Vice President 1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55120
John D Buck director 4201 GULF SHORE BLVD NORTH, APT 1703N, NAPLES FL 34103